Serum Lactate in Acute Mesenteric Ischemia
Serum Lactate in Acute Mesenteric Ischemia
Background: Acute mesenteric ischemia is a vascular emergency with high mortality because of
 ambiguous symptomatology and a lack of early diagnostic markers. Lactate dehydrogenase has
 been described as a mortality biomarker and bowel necrosis length too. Nevertheless, the
 association between them has been mildly studied. Our objective was to evaluate the
 association between serum lactate admission levels, bowel necrosis extension, and mortality.
 Additionally, we performed a mortality characterization.

 Materials and Methods: A retrospective cross-sectional study was designed. We reviewed
 patients' clinical records with acute mesenteric ischemia that attended a hospital between
 2012 and 2018. We compared serum lactate admission levels with bowel necrosis length and
 mortality. A receiver operating characteristic curve was performed on the last association.
 As post hoc analysis, a classification and regression tree on mortality was fitted.
Inclusion Criteria:

 -  Older than 18 years of age

 -  Required urgent laparotomy with a postoperative diagnosis of acute mesenteric ischemia

 -  Attended the private academic hospital, between 2012 and 2018

 -  Had a registered serum lactate dehydrogenase at admission

 Exclusion Criteria:

 -  Secondary causes of AMI

 -  Chronic intestinal ischemic

 -  Patient records with no description of the serum lactate dehydrogenase or extension of
 intestinal necrosis